CHENNAI: Chennai-based Iswarya Fertility Centre (Iswarya), on Thursday announced a growth investment of more than Rs 350 crore (approximately $37 million) from OrbiMed Asia (OrbiMed).
The investment marks a significant milestone in Iswarya’s mission to expand the reach of fertility care across India and help address the country’s declining birth rates.
Established in 1986, Iswarya is among the south's largest fertility network with 85+ centres across eight states, serving over 300,000 couples over four decades.
Dr Arun Muthuvel, managing director, Iswarya Fertility Center, said "Our focus over the next phase is clear: deepen our pan-India presence, enter underserved geographies and keep raising the bar on clinical outcomes.”
Dr S Chandralekha, founder and chief clinical officer, Iswarya Fertility Center, said: "When we started Iswarya, IVF was beyond the reach of most Indian families. From the very beginning, every center we have opened has been guided by a simple belief: clinical excellence and compassion must always go hand in hand.”
Veda Corporate Advisors were the financial advisors to the company and its promoters.